Fotiou S, Hatjieleftheriou G, Kyrousis G, Kokka F, Apostolikas N
Department of Gynecology, Saint Savas Cancer Hospital of Athens, Greece. FosteOTENET.GR
Anticancer Res. 2000 May-Jun;20(3B):2015-20.
Two cases of uterine carcinosarcoma developing after long-term tamoxifen (TAM) treatment are presented. The patients, 67 and 72 years old, were treated with TAM for 6 and 7 years, continuously. They both developed an heterologous malignant mixed Mullerian tumor (mmMt). At laparotomy, an advanced stage of disease was found with peritoneal spread. In spite of the surgical and the postoperative treatment, they both died of disease, 3 and 10 months later. There are only 10, well documented, similar cases reported. Another 7 were identified in series of uterine malignancies developing after TAM treatment. Considerable evidence suggests that mmMt represents an epithelial cancer with sarcomatous dedifferentiation. Prolonged (> 5 years) TAM treatment may represent a causative factor in the development of this highly lethal disease (80% of the reported patients had a dismal prognosis). Large uterine polyps with special histological features, may represent an intermediate step in the tumor formation. Close follow-up of the patients is warranted.
本文报告两例长期服用他莫昔芬(TAM)后发生子宫癌肉瘤的病例。两名患者年龄分别为67岁和72岁,持续服用TAM 6年和7年。她们均发生了异源性恶性混合苗勒管肿瘤(mmMt)。剖腹探查时发现疾病已处于晚期并有腹膜播散。尽管进行了手术及术后治疗,但她们分别在3个月和10个月后均死于该疾病。仅有10例记录良好的类似病例报道。在TAM治疗后发生的一系列子宫恶性肿瘤中又发现了另外7例。大量证据表明,mmMt是一种伴有肉瘤样去分化的上皮癌。长期(>5年)TAM治疗可能是这种高致死性疾病发生的一个致病因素(80%的报道患者预后不良)。具有特殊组织学特征的大子宫息肉可能是肿瘤形成的一个中间阶段。对患者进行密切随访是必要的。